Aurora Diagnostics Announces Sale of Greensboro, N.C., Blood
Testing Laboratory to Dominion Diagnostics
Sale Allows Aurora to Focus on its Anatomic Pathology Practices;
Dominion Diagnostics to Launch Clinical Pathology Division
PALM BEACH GARDENS, Fla., and NORTH KINGSTOWN, R.I. – Aurora Diagnostics, the
leading independent specialized laboratory company focused on anatomic pathology,
announced today that it has sold its Greensboro, N.C., blood testing clinical laboratory to
Dominion Diagnostics, effective December 31, 2014.
Terms of the transaction were not disclosed.
“We are pleased to complete this transaction, which allows us to focus our efforts and resources
on our core business of anatomic pathology,” said Daniel D. Crowley, CEO of Aurora
Diagnostics. Aurora has entered into a laboratory services agreement with Dominion
Diagnostics to perform clinical analysis for Aurora’s Greensboro pathology laboratory.
Dominion Diagnostics, headquartered in North Kingstown, R.I., is a leading, certified and
accredited national medical laboratory that provides drug monitoring solutions and actionable
clinical information to improve patient care and treatment outcomes in addiction medicine,
chronic pain management and other healthcare specialties.
“This successful transaction with Aurora supports our ongoing commitment to advance
treatment outcomes and improve patient care,” says Bob Garvey, CEO of Dominion
Diagnostics. “The launch of a new clinical pathology division in Greensboro will allow us to
meet Aurora’s continued pathology needs and better address the needs of our clients and
patients.”
Beyond the expansion into clinical pathology made possible through the Greensboro laboratory
acquisition, Dominion Diagnostics will initiate aggressive clinical research and development to
launch new products and services that complement and expand upon its core business.
About Aurora Diagnostics
Aurora Diagnostics is the leading independent specialized laboratory company focused on
anatomic pathology at 23 locations in the United States. Employing over 120 licensed
physicians, Aurora Diagnostics provides high-quality diagnostics and testing information for the
patients of its primary referral sources—dermatologists, OB/GYN professionals,
gastroenterologists, urologists, general surgeons, oncologists, and for more than 60 community
hospitals. For additional information regarding Aurora Diagnostics and the services it provides,
please visit the company website at www.auroradx.com.
About Dominion Diagnostics
Dominion Diagnostics is a leading national laboratory that offers clinical drug testing,
prescription monitoring services, and a full suite of clinical support solutions. Since 1997,
2
Dominion Diagnostics has provided services to clients representing a diversity of medical
specialties across the United States, including addiction medicine, behavioral health, pain
medicine, primary care, psychiatry, and hospital systems. Dominion Diagnostics is supported by
a world‐class team that shares a commitment to clinical excellence, compliance, and integrity.
For more information, please visit www.dominiondiagnostics.com.
Aurora Media Relations Contact:
Bill Halldin, Halldin Public Relations | (916) 781-0657 | bill@halldinpr.com
Dominion Diagnostics Media Relations Contact:
Julie Lenahan, Dominion Diagnostics | (401) 578-3326 | jlenahan@dominiondiagnostics.com
Forward Looking Statements
Certain matters discussed in this press release may constitute forward-looking statements
within the meaning of federal securities laws. Actual results and the timing of certain events
could differ materially from those projected in or contemplated by the forward-looking
statements due to a number of factors, some of which are not within the control of the
Company. Aurora reports information that may be significant for investors in its filings with the
Securities and Exchange Commission (SEC), and Aurora encourages investors to consult those
filings.